188 related articles for article (PubMed ID: 14985960)
1. Plasma and lung concentrations of ceftazidime administered in continuous infusion to critically ill patients with severe nosocomial pneumonia.
Boselli E; Breilh D; Rimmelé T; Poupelin JC; Saux MC; Chassard D; Allaouchiche B
Intensive Care Med; 2004 May; 30(5):989-91. PubMed ID: 14985960
[TBL] [Abstract][Full Text] [Related]
2. Steady-state plasma and intrapulmonary concentrations of piperacillin/tazobactam 4 g/0.5 g administered to critically ill patients with severe nosocomial pneumonia.
Boselli E; Breilh D; Cannesson M; Xuereb F; Rimmelé T; Chassard D; Saux MC; Allaouchiche B
Intensive Care Med; 2004 May; 30(5):976-9. PubMed ID: 15057512
[TBL] [Abstract][Full Text] [Related]
3. Steady-state plasma and intrapulmonary concentrations of cefepime administered in continuous infusion in critically ill patients with severe nosocomial pneumonia.
Boselli E; Breilh D; Duflo F; Saux MC; Debon R; Chassard D; Allaouchiche B
Crit Care Med; 2003 Aug; 31(8):2102-6. PubMed ID: 12973166
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacodynamic interest of ceftazidime continuous infusion vs intermittent bolus administration in patients with severe nosocomial pneumonia].
Cousson J; Floch T; Vernet-Garnier V; Appriou M; Petit JS; Jovenin N; Lamiable D; Hoizey G
Pathol Biol (Paris); 2005; 53(8-9):546-50. PubMed ID: 16023303
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia.
Boselli E; Breilh D; Rimmelé T; Djabarouti S; Toutain J; Chassard D; Saux MC; Allaouchiche B
Crit Care Med; 2005 Jul; 33(7):1529-33. PubMed ID: 16003058
[TBL] [Abstract][Full Text] [Related]
6. Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study.
Frippiat F; Musuamba FT; Seidel L; Albert A; Denooz R; Charlier C; Van Bambeke F; Wallemacq P; Descy J; Lambermont B; Layios N; Damas P; Moutschen M
J Antimicrob Chemother; 2015 Jan; 70(1):207-16. PubMed ID: 25216821
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and lung concentrations of ertapenem in patients with ventilator-associated pneumonia.
Boselli E; Breilh D; Saux MC; Gordien JB; Allaouchiche B
Intensive Care Med; 2006 Dec; 32(12):2059-62. PubMed ID: 17039351
[TBL] [Abstract][Full Text] [Related]
8. Lung concentrations of ceftazidime administered by continuous versus intermittent infusion in patients with ventilator-associated pneumonia.
Cousson J; Floch T; Guillard T; Vernet V; Raclot P; Wolak-Thierry A; Jolly D
Antimicrob Agents Chemother; 2015 Apr; 59(4):1905-9. PubMed ID: 25583727
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and intrapulmonary diffusion of levofloxacin in critically ill patients with severe community-acquired pneumonia.
Boselli E; Breilh D; Rimmelé T; Djabarouti S; Saux MC; Chassard D; Allaouchiche B
Crit Care Med; 2005 Jan; 33(1):104-9. PubMed ID: 15644655
[TBL] [Abstract][Full Text] [Related]
10. Steady-state trough serum and epithelial lining fluid concentrations of teicoplanin 12 mg/kg per day in patients with ventilator-associated pneumonia.
Mimoz O; Rolland D; Adoun M; Marchand S; Breilh D; Brumpt I; Debaene B; Couet W
Intensive Care Med; 2006 May; 32(5):775-9. PubMed ID: 16550370
[TBL] [Abstract][Full Text] [Related]
11. Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial.
Benítez-Cano A; Luque S; Sorlí L; Carazo J; Ramos I; Campillo N; Curull V; Sánchez-Font A; Vilaplana C; Horcajada JP; Adalia R; Bermejo S; Samsó E; Hope W; Grau S
Crit Care; 2020 Feb; 24(1):55. PubMed ID: 32066497
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of ceftazidime by continuous infusion versus intermittent infusion for nosocomial pneumonia.
McNabb JJ; Nightingale CH; Quintiliani R; Nicolau DP
Pharmacotherapy; 2001 May; 21(5):549-55. PubMed ID: 11349744
[TBL] [Abstract][Full Text] [Related]
13. Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation.
Mariat C; Venet C; Jehl F; Mwewa S; Lazarevic V; Diconne E; Fonsale N; Carricajo A; Guyomarc'h S; Vermesch R; Aubert G; Bidault R; Bertrand JC; Zeni F
Crit Care; 2006 Feb; 10(1):R26. PubMed ID: 16507147
[TBL] [Abstract][Full Text] [Related]
14. Nebulized ceftazidime in experimental pneumonia caused by partially resistant Pseudomonas aeruginosa.
Ferrari F; Lu Q; Girardi C; Petitjean O; Marquette CH; Wallet F; Rouby JJ;
Intensive Care Med; 2009 Oct; 35(10):1792-800. PubMed ID: 19652947
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review.
Lorente L; Jiménez A; Palmero S; Jiménez JJ; Iribarren JL; Santana M; Martín MM; Mora ML
Clin Ther; 2007 Nov; 29(11):2433-9. PubMed ID: 18158083
[TBL] [Abstract][Full Text] [Related]
16. Intrapulmonary pharmacokinetics of antibiotics used to treat nosocomial pneumonia caused by Gram-negative bacilli: A systematic review.
Heffernan AJ; Sime FB; Lipman J; Dhanani J; Andrews K; Ellwood D; Grimwood K; Roberts JA
Int J Antimicrob Agents; 2019 Mar; 53(3):234-245. PubMed ID: 30472292
[TBL] [Abstract][Full Text] [Related]
17. Alveolar diffusion and pharmacokinetics of linezolid administered in continuous infusion to critically ill patients with ventilator-associated pneumonia.
Boselli E; Breilh D; Caillault-Sergent A; Djabarouti S; Guillaume C; Xuereb F; Bouvet L; Rimmelé T; Saux MC; Allaouchiche B
J Antimicrob Chemother; 2012 May; 67(5):1207-10. PubMed ID: 22351682
[TBL] [Abstract][Full Text] [Related]
18. Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia.
Nicolau DP; McNabb J; Lacy MK; Quintiliani R; Nightingale CH
Int J Antimicrob Agents; 2001 Jun; 17(6):497-504. PubMed ID: 11397621
[TBL] [Abstract][Full Text] [Related]
19. Reliability of mini-bronchoalveolar lavage for the measurement of epithelial lining fluid concentrations of tobramycin in critically ill patients.
Boselli E; Breilh D; Djabarouti S; Guillaume C; Rimmelé T; Gordien JB; Xuereb F; Saux MC; Allaouchiche B
Intensive Care Med; 2007 Sep; 33(9):1519-23. PubMed ID: 17530217
[TBL] [Abstract][Full Text] [Related]
20. Lung deposition of continuous and intermittent intravenous ceftazidime in experimental Pseudomonas aeruginosa bronchopneumonia.
Girardi C; Tonnellier M; Goldstein I; Sartorius A; Wallet F; Rouby JJ;
Intensive Care Med; 2006 Dec; 32(12):2042-8. PubMed ID: 16858611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
